As reported by DailyRX.com, Ranbaxy Pharmaceuticals Inc. recently announced a large-scale recall of atorvastatin calcium, the generic form of Lipitor, which is a popular cholesterol medication. Officials with the pharmaceutical company state that the recall is a precautionary measure after certain batches were found to contain glass particles “resembling a fine grain of sand.” As the particles of glass were very small, officials state that it is unlikely to cause a serious safety concern, but the possibility of physical irritation from swallowing pills with tiny glass shards is possible.
Presently, there are no reports of adverse events associated with the generic drug, but Ranbaxy has advised patients taking the medicine that may be affected to consult with a doctor immediately if experience any issues while taking the drug. Retailers and distributors have been asked to return the affected medication. The company will no longer manufacture the medication until the source of the potential contamination has been determined.
The voluntary recall includes 41 lots of medication, each containing 1,000 pills, of the 10, 20, and 40 milligram strengths.
A defective or dangerous drug has the potential to threaten the health and wellbeing of an unsuspecting patient, and defects are often not found until it is too late. The Walnut Creek dangerous drugs attorneys of Balamuth Law have the resources and skills needed to prove liability in your case and will work tirelessly to ensure negligent manufacturers are held accountable for the harm caused. To see how we can help you obtain the compensation that can help you recover well, call (888) 254-1234.
Following a previous recall, an additional number of bottles of Lipitor have been recalled by the drug’s manufacturer, Pfizer, according to ABCNews.com. Thousands of bottles of the cholesterol lowering drug have been found to have a musty odor.
The recall has been ongoing since August, but was not made public until October. Recently, about 19,000 more bottles with the smell were discovered. This brings the total number of recalled bottles to 360,000.
The smell is due to the presence of a chemical called 2,4,6-tribromoanisole (TBA). In low concentrations, TBA, has very minimal health effects, mainly gastrointestinal issues. The TBA may come from the wood pallets that are used to transport many consumer goods. However, Pfizer prohibits the use of chemically treated wood to ship its products, according to a company spokesman. According to the drug manufacturer, any customers who smell a musty odor coming from Lipitor should return it to their pharmacist.
Companies that manufacture drugs are responsible for making those drugs safe for consumers. A drug manufacturer can be held liable if it fails to warn of dangers or side effects associated with the drug, if the drug is defective or causes injury, or if the manufacturer doesn’t provide instructions for use of the drug.
If you have suffered an illness or injury due to a contaminated or defective prescription medication, contact the Northern California dangerous drug attorneys at Balamuth Harrington. Our experienced lawyers can help you get the compensation you deserve for your drug-related injuries. Call us today at 1-888-254-1234.
- Accountant Malpractice
- Auto Collision
- Auto Maintenance
- Auto Product Liability
- Brain Injury
- Burn Injury
- Bus Accidents
- Child Injury
- Compressed Gas Accident
- Construction Site Injuries
- Dangerous Drugs
- Dangerous Products
- Dangerous Toys Child Products
- Dog Bite Attack
- Firm News
- Legal Malpractice
- Manufacturing Defect
- Pedestrian Accident
- Personal Injury
- Premises Liability
- Scaffolding Accidents
- Slip and Fall Accident
- Train Accidents
- Truck Accidents
- Work Injury
- Wrongful Death
- Be Aware Of Drunk Drivers During The Holidays
- Bicycling Accidents in the Bay Area
- Oakland Community Rallies for Improved Street Safety Following Deadly Hit and Run
- Bicyclist Fatality Provides a Stark Reminder of the Importance of Bike Safety
- 4 Dead in Wrong-Way Crash on Highway 101